|
|
||||||||
and Fc
Modules Utilizing Differential Reduction of Interchain Disulfide Bonds1





*
Biological Sciences, University of North London, London, United Kingdom;
Tenovus Research Laboratory, Southampton University Hospitals, Southampton, United Kingdom; and
The Edward Jenner Institute for Vaccine, Compton, United Kingdom
We describe a two-stage preparation of chemically engineered Ab
constructs, employing as modules Fab'
from mAb or rAb, and Fc from
human normal IgG1. A multivalent, optionally multispecific
F(ab')n core is formed in stage one, and one or more Fc
modules added in stage two. Examples include bispecific
Fab2Fc2 (for simplicity, primes and Greek
letters are omitted from names of final constructs) and trivalent
Fab3Fc2, which are designed to kill neoplastic
cells. An essential element in the construction is the availability of
the Fab' in two reduced forms, Fab'(-sulfhydryl (SH))5 and
Fab'-SH. The first is obtained by full reduction of the interchain
disulfide bonds (SS) in the F(ab')2 fragment of IgG.
Fab'-SH is obtained by disulfide-interchange reactions on
Fab'(-SH)5, whereby the
-light SS is reconstituted, an
unusual intrachain SS forms in the
-chain hinge, and one hinge SH
remains. F(ab')2 and F(ab')3 cores are built
using partially reduced modules, being given intermodular thioether
links that resist reduction. These cores are then fully reduced, making
available SH groups for addition of the Fc
modules. In the final
constructs, all intermodular links embody tandem thioether bonds
arising at hinge-region cysteines. Cytotoxic activities of
representative constructs, and some enhancements deriving from multiple
modules, are assessed. In guinea pigs, catabolism of
Fab2Fc2 yielded a
t1/2 similar to that of human IgG1, although
the serum Fab2Fc2 revealed some proteolytic
breakdown not shown by the IgG1. Immunotherapy of a guinea-pig leukemia
confirmed the ability of these constructs to kill target cells in
vivo.
This article has been cited by other articles:
![]() |
K. Miller, G. Meng, J. Liu, A. Hurst, V. Hsei, W.-L. Wong, R. Ekert, D. Lawrence, S. Sherwood, L. DeForge, et al. Design, Construction, and In Vitro Analyses of Multivalent Antibodies J. Immunol., May 1, 2003; 170(9): 4854 - 4861. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |